No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.
This page is free to read, and it stops after 5 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.
Filings
Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.
| Company | Type | Value | Reported | Company | Value | Type | Shares | Reported |
|---|---|---|---|---|---|---|---|---|
| NovaBridge BiosciencesChief Bus. Development Officer | Open-market sell | $79,904107,978 shares | Sep 11, 2026 | NovaBridge BiosciencesChief Bus. Development Officer | $79,904 | Open-market sell | 107,978 | Sep 11, 2026 |
| NovaBridge BiosciencesChief Bus. Development Officer | Option exercise | nothing paid45,320 shares | Sep 8, 2026 | NovaBridge BiosciencesChief Bus. Development Officer | nothing paid | Option exercise | 45,320 | Sep 8, 2026 |
| NovaBridge BiosciencesChief Bus. Development Officer | Option exercise | nothing paid102,233 shares | Sep 8, 2026 | NovaBridge BiosciencesChief Bus. Development Officer | nothing paid | Option exercise | 102,233 | Sep 8, 2026 |
| NovaBridge BiosciencesChief Bus. Development Officer | Option exercise | —104,236 shares | Sep 8, 2026 | NovaBridge BiosciencesChief Bus. Development Officer | — | Option exercise | 104,236 | Sep 8, 2026 |
| NovaBridge BiosciencesChief Bus. Development Officer | Option exercise | —235,136 shares | Sep 8, 2026 | NovaBridge BiosciencesChief Bus. Development Officer | — | Option exercise | 235,136 | Sep 8, 2026 |